Clinical Trial Update: Effect of Lidocaine-Dexmedetomidine on Pain, Inflammation, and Oxidative Stress After Bariatric Surgery. [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial is evaluating lidocaine-dexmedetomidine for pain, inflammation, and oxidative stress after bariatric surgery. The study is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Morbid Obesity

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)
• Lidocaine (Lidocaine)

Snippet

Sponsor: Instituto Mexicano del Seguro Social | Conditions: Morbid Obesity Requiring Bariatric Surgery, Postoperative Pain | Phase 4 | Status: RECRUITING